Abstract:Seven undescribed sesquiterpenes, including three dimeric guaianolide sesquiterpenes artemongolides G-I (1-3) and four sesquiterpene lactones artemanomalide D-G (16-19), along with seventeen known compounds isoabsinthin (4), absinthin (5), 11-eptabsinthin (6), 11, 11'-bis-epiabsinthin (7), 10', 11'- epiabsinthin (8), anabsinthin (9), isoanabsinthin (10), absinthin D (11), anabsin (12), caruifolin D (13), gnapholide (14), caruifolin C (15), 1β(R),10β(S)-dihydroxy-3-oxo-11β (S)H-4,11(13)-guaien-6α(S),12-olide (20), 1α,6α,8α-trihydroxy-5α,7βH-guaia-3,10(14),11(13)-trien-12-oic acid (21), 1α,6α,8α-trihydroxy-5α,7βH-guaia-3,9,11(13)-trien-12-oic acid (22), argyinolide J (23), artabsinolide A (24) were isolated from the plant Artemisia mongolica. The structures were determined by interpreting NMR, HRESIMS and ECD data. The X-ray crystal structure of 4, 7 and 8 were reported for the first time. In the anti-vitiligo activity test, compounds 2, 7, 12, 23 and 24 demonstrated activity in promoting melanogenesis at a concentration of 50 μM in B16 cells, with 8-methoxypsoralan (8-MOP) as a positive control. Further research on the mechanism revealed that artemongolides H (2) enhance the expression of MITF and TRPs by upregulating p-Akt and p-GSK-3β, leading to an increase in β-catenin content in the cell cytoplasm. Subsequently, β-catenin translocates into the nucleus, resulting in melanogenesis. The results supported the regulation of melanogenesis by artemongolide H (2) through the Akt/GSK3β/β-catenin signaling pathway. The anti-inflammatory results demonstrated that compounds 4, 5, 6, 9 and 14 can inhibit the upregulation of IL-6 mRNA and CCL2 mRNA expression. Compound 12 specifically inhibited the upregulation of IL-6 mRNA expression. These compounds exhibited significant anti-inflammatory activities. The activity results revealed that these sesquiterpene compounds have the potential to become lead compounds for the treatment of vitiligo and inflammatory diseases.

Glechomenes A-G, diterpenoids with anti-inflammatory activities from the aerial part of Glechoma longituba

Terpenoids with Anti-Inflammatory Activity from Abies Chensiensis.

Three New Norlignans Fromglechoma Longituba

Diverse terpenoid glycosides with in vitro cytotoxicity from Glechoma longituba

Diterpenoid glucosides with anti-inflammatory activity from Sigesbeckia glabrescens

Guaianolide sesquiterpenes and their activity from Artemisia mongolica

Glaucatotones A−I: Guaiane-type sesquiterpenoids from the roots of Lindera glauca with anti-inflammatory activity

Chemical Constituents from Gueldenstaedtia Verna and Their Anti-Inflammatory Activity

Six undescribed guaianolide-type sesquiterpenes from the aerial parts of Daphne penicillata

Sesquiterpenes from Artemisia Sieversiana and their anti-inflammatory activities

Terpenoids from Tripterygium hypoglaucum and Their Anti-Inflammatory Activity

Further terpenoids from the Chloranthaceae plant Chloranthus multistachys and their anti-neuroinflammatory activities

ent-Pimarane diterpenoids from Siegesbeckia glabrescens with anti-inflammatory activity

Guaianolide-type sesquiterpene lactones from Achillea millefolium L. and their anti-inflammatory activity

Dimeric guaianolides and sesquiterpenoids from Artemisia anomala.

Terpenoid and phenolic derivatives from the aerial parts of Elsholtzia rugulosa and their anti-inflammatory activity

Four pairs of new enantiomeric guaiane sesquiterpenoids from the rhizomes of Alisma plantago-aquatica

ent ‐Pimarane Diterpenoid Dimers from Sigesbeckia glabrescens with Potent Anti‐inflammatory Activities

Guaianolides from Achillea millefolium L. and their anti-inflammatory activity

Terpenoids from Alpinia galanga and their acetylcholinesterase inhibitory activity

Anti-inflammatory Abietanes Diterpenoids Isolated from Tripterygium Hypoglaucum.